These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10325833)

  • 41. Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery.
    Mirow N; Zittermann A; Koertke H; Maleszka A; Knobl H; Coskun T; Kleesiek K; Koerfer R
    J Cardiovasc Surg (Torino); 2008 Apr; 49(2):277-84. PubMed ID: 18431350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets.
    Mirow N; Brinkmann T; Minami K; Tenderich G; Schulte-Eistrup S; Kleesiek K; Körfer R
    J Cardiovasc Surg (Torino); 2001 Oct; 42(5):579-85. PubMed ID: 11562580
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of A heparin-coated circuit for extracorporeal circulation with selective cerebral perfusion.
    Hattori K; Suehiro S; Shibata T; Sasaki Y; Kumano H; Kinoshita H
    Osaka City Med J; 2000 Dec; 46(2):111-8. PubMed ID: 11252730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin.
    Mollnes TE; Videm V; Götze O; Harboe M; Oppermann M
    Ann Thorac Surg; 1991 Jul; 52(1):92-7. PubMed ID: 2069469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation.
    Wendel HP; Ziemer G
    Eur J Cardiothorac Surg; 1999 Sep; 16(3):342-50. PubMed ID: 10554855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Importance of uniform heparin coating on biopolymers.
    Da Luz Moreira P; Wada ML; Novello WP
    Artif Organs; 2000 Mar; 24(3):209-11. PubMed ID: 10759643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complement consumption during cardiopulmonary bypass: comparison of Duraflo II heparin-coated and uncoated circuits in fully heparinized patients.
    Hamulu A; Dişcigil B; Ozbaran M; Calkavur T; Kara E; Kokuludağ A; Büket S; Bilkay O
    Perfusion; 1996 Jul; 11(4):333-7. PubMed ID: 8884862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New surface biopolymers for oxygenators: an in vitro hemocompatibility test of poly(2-methoxyethylacrylate).
    Baykut D; Bernet F; Wehrle J; Weichelt K; Schwartz P; Zerkowski HR
    Eur J Med Res; 2001 Jul; 6(7):297-305. PubMed ID: 11485890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits.
    Videm V; Mollnes TE; Garred P; Svennevig JL
    J Thorac Cardiovasc Surg; 1991 Apr; 101(4):654-60. PubMed ID: 2008104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts.
    Gunaydin S; McCusker K; Sari T; Onur MA; Zorlutuna Y
    Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):371-6. PubMed ID: 20026488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Heparin concentration and hemostatic alterations with low systemic heparinization during CPB using heparin-coated circuits].
    Yoshie M; Hirose Y; Gamo M; Matsuo K
    Masui; 2001 Feb; 50(2):179-83. PubMed ID: 11244775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical outcome after coronary surgery with heparin-coated extracorporeal circuits for cardiopulmonary bypass.
    Baufreton C; Le Besnerais P; Jansen P; Mazzucotelli JP; Wildevuur CR; Loisance DY
    Perfusion; 1996 Nov; 11(6):437-43. PubMed ID: 8971943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Arterial-venous perfusion without anticoagulation: the impeller centrifugal pump.
    Vertrees RA; Yu Y; Wacker C; Cernaianu AC; DelRossi AJ
    J Extra Corpor Technol; 1991; 22(4):160-3. PubMed ID: 10149016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Preparation and antithrombogenicity of oxidated low molecular weight heparin-antithrombin complex coated-polyvinyl chloride tubing].
    Luo P; Liu W; Yang C; Zhou H; Cao R; Yang J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Feb; 28(1):90-4. PubMed ID: 21485191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity of anticoagulant proteins on the polymer-coated and heparin-coated membranes in an extracorporeal circulation circuit.
    Tagaya M; Murataka T; Okano S; Handa H; Tanaka Y; Takahashi S
    Perfusion; 2023 Apr; 38(3):600-608. PubMed ID: 35098806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is using an open-reservoir cardiopulmonary bypass circuit after 6 days on standby safe?
    Tagaya M; Matsuda M; Ryugo M; Takasaki T; Kurita S; Handa H; Hara K
    Interact Cardiovasc Thorac Surg; 2016 Feb; 22(2):155-60. PubMed ID: 26573764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved blood cellular biocompatibility with heparin coated circuits during cardiopulmonary bypass.
    Belboul A; Akbar O; Löfgren C; Jungbeck M; Storm C; Roberts A
    J Cardiovasc Surg (Torino); 2000 Jun; 41(3):357-62. PubMed ID: 10952323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A heparin-coated circuit reduces complement activation and the release of leukocyte inflammatory mediators during extracorporeal circulation in a rabbit.
    Plötz FB; van Oeveren W; Hultquist KA; Miller C; Bartlett RH; Wildevuur CR
    Artif Organs; 1992 Aug; 16(4):366-70. PubMed ID: 10078276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Release of lipopolysaccharide toxicity-modulating proteins in patients undergoing cardiopulmonary bypass using noncoated and heparin-coated extracorporeal circuits. A clinical pilot study.
    Bouma M; Maessen J; Weerwind P; Dentener M; Fransen E; de Jong D; Buurman W
    Chest; 1997 Mar; 111(3):577-83. PubMed ID: 9118690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.